203 related articles for article (PubMed ID: 16207308)
1. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration.
Robertson SA; Lascelles BD; Taylor PM; Sear JW
J Vet Pharmacol Ther; 2005 Oct; 28(5):453-60. PubMed ID: 16207308
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.
Abbo LA; Ko JC; Maxwell LK; Galinsky RE; Moody DE; Johnson BM; Fang WB
Vet Ther; 2008; 9(2):83-93. PubMed ID: 18597246
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations and behavioral, antinociceptive, and physiologic effects of methadone after intravenous and oral transmucosal administration in cats.
Ferreira TH; Rezende ML; Mama KR; Hudachek SF; Aguiar AJ
Am J Vet Res; 2011 Jun; 72(6):764-71. PubMed ID: 21627522
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.
Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P
PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold.
Hedges AR; Pypendop BH; Shilo-Benjamini Y; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2014 Jun; 37(3):252-9. PubMed ID: 24862514
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma concentrations and analgesia after intravenous fentanyl and disposition after other routes of administration in cats.
Robertson SA; Taylor PM; Sear JW; Keuhnel G
J Vet Pharmacol Ther; 2005 Feb; 28(1):87-93. PubMed ID: 15720520
[TBL] [Abstract][Full Text] [Related]
9. Sedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular administration in cats.
Porters N; Bosmans T; Debille M; de Rooster H; Duchateau L; Polis I
Vet Anaesth Analg; 2014 Jan; 41(1):90-6. PubMed ID: 23910721
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine in combination with naloxone at a ratio of 15:1 does not enhance antinociception from buprenorphine in healthy cats.
Slingsby LS; Murrell JC; Taylor PM
Vet J; 2012 Jun; 192(3):523-4. PubMed ID: 22030474
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oral transmucosal and intramuscular dexmedetomidine combined with buprenorphine in cats.
Porters N; de Rooster H; Bosmans T; Baert K; Cherlet M; Croubels S; De Backer P; Polis I
J Vet Pharmacol Ther; 2015 Apr; 38(2):203-8. PubMed ID: 25269566
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
Krotscheck U; Boothe DM; Little AA
Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
[TBL] [Abstract][Full Text] [Related]
13. Postoperative analgesic effects of intravenous, intramuscular, subcutaneous or oral transmucosal buprenorphine administered to cats undergoing ovariohysterectomy.
Giordano T; Steagall PV; Ferreira TH; Minto BW; de Sá Lorena SE; Brondani J; Luna SP
Vet Anaesth Analg; 2010 Jul; 37(4):357-66. PubMed ID: 20636568
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects of butorphanol, buprenorphine, or both, administered intramuscularly in cats.
Johnson JA; Robertson SA; Pypendop BH
Am J Vet Res; 2007 Jul; 68(7):699-703. PubMed ID: 17605603
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
Davis JL; Messenger KM; LaFevers DH; Barlow BM; Posner LP
J Vet Pharmacol Ther; 2012 Feb; 35(1):52-8. PubMed ID: 21392040
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC
J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of buprenorphine from crushed and whole buprenorphine (subutex) tablets.
Simojoki K; Lillsunde P; Lintzeris N; Alho H
Eur Addict Res; 2010; 16(2):85-90. PubMed ID: 20130408
[TBL] [Abstract][Full Text] [Related]
18. Dose-related antinociceptive effects of intravenous buprenorphine in cats.
Steagall PV; Mantovani FB; Taylor PM; Dixon MJ; Luna SP
Vet J; 2009 Nov; 182(2):203-9. PubMed ID: 18691917
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of buprenorphine in healthy, lactating goats.
Ingvast-Larsson C; Svartberg K; Hydbring-Sandberg E; Bondesson U; Olsson K
J Vet Pharmacol Ther; 2007 Jun; 30(3):249-56. PubMed ID: 17472657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
